An efficient component of the redundancy calibration program to ensure equipment stability by assaying HDR Ir-192 sources at the time of replacement.

Autors de IIS La Fe
Grups d'Investigació
Abstract
BACKGROUND: Brachytherapy (BT) treatments involving temporary high-dose rate (HDR) sources are extensively employed in clinical practice. Ensuring the consistency of all measurement equipment at the hospital level is crucial, requiring a robust redundancy and consistency program. This enables the institution to verify the stability of the dosimetry system over time. PURPOSE: To describe, justify, and analyze a component of the redundancy program of the calibration protocols followed by the Radiotherapy Department of the Hospital Universitari i Politècnic La Fe (València, Spain) during the last 10 years for the case of HDR BT as an additional component to ensure long term stability of the measurement equipment. METHODS: At the time the HDR BT source is replaced, its Air Kerma Strength (S(K)) is measured. By comparing this value with the one obtained at the time of installation (corrected by decay), a clear determination of the stability of the measurement equipment can be performed. RESULTS: Difference between S(K,vendor) and S(K,hosp) as a function of the measurement date is reported for a 10 years' period. All measurements are well within the ±3% tolerance level recommended in current international guidelines. Percentage differences of S(K,hosp) values at the time of replacement compared to S(K,hosp) ones at the time when the source was installed are within the ±0.5% range, reflecting oscillations around a null deviation. CONCLUSIONS: The method proposed allows any hospital to ensure a redundancy component of the long-term stability of all equipment involved in BT measurements in a very simple and time efficient manner. Additionally, it enables the hospital to maintain a detailed log of historical differences, facilitating the identification and correction of potential systematic deviations over time.
© 2024 The Author(s). Journal of Applied Clinical Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.
Dades de la publicació
- ISSN/ISSNe:
- 1526-9914, 1526-9914
- Tipus:
- Article
- Pàgines:
- -
- DOI:
- 10.1002/acm2.14509
- PubMed:
- 39238193
- Factor d'Impacte:
- 0,656 SCImago ℠
- Quartil:
- Q2 SCImago ℠
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS American Institute of Physics
Documents
- No hi ha documents
Filiacions
Keywords
- brachytherapy
Projectes associats
ESTUDIO DE BRAQUITERAPIA ELECTRÓNICA PARA CARCINOMA CUTÁNEO BASOCELULAR.
Investigador Principal: JOSÉ PÉREZ CALATAYUD
BCCBRACHY
A RANDOMIZED, DOUBLÉ-BLIND, PLACEBO-CONTROLLE ADJUVANT TRIAL IN NEWLY DIAGNOSED PRIMARY GLIOBLASTOMA SUBJECTS TO ASSESS THE EFFICACY AND SAFETY OF 2-HYDROXYLEIC ACID (2-OHOA) IN COMBINATION WITH RADIOTHERAPY AND TEMOZOLMIDE STANDARD OF CARE TREATMENT.
Investigador Principal: REGINA GIRONÉS SARRIÓ
MIN-003-1806 . 2019
Estudio Fase 1b, abierto, de búsqueda de dosis de CC-90010 en combinación con temozolomida con o sin radioterapia en sujetos con glioblastoma de nuevo diagnóstico.
Investigador Principal: REGINA GIRONÉS SARRIÓ
CC-90010-GBM-002 . 2022
MATTO-GBM FCAECC-Multimodality Artificial intelligence open-source Tools for Radiation Treatment Optimization in patients with Glioblastoma.
Investigador Principal: LUIS MARTÍ BONMATÍ
TRANSCAN-3 JTC2022 . COMISION EUROPEA . 2023
Análisis de biomarcadores de efecto abscopal en pacientes tratados con radio-inmunoterapia.
Investigador Principal: RODOLFO CHICAS SET
2023-1061-1 . 2024
DeTeRMIA .Desarrollo de Técnicas Avanzadas de RM para el Diagnóstico Rápido del Cáncer de Próstata.
Investigador Principal: LEONOR CERDÁ ALBERICH
PMPTA23/00010 . INSTITUTO DE SALUD CARLOS III . 2024